Bivalirudin exerts antiviral activity against respiratory syncytial virus-induced lung infections in neonatal mice
By: Shihao Zhuang, Qiuyu Tang, Ping Chen, Chengyi Wang and Guanghua Liu
Authors
Shihao Zhuang
Department of Pediatrics, Fujian Children’s Hospital, China
Department of Pediatrics, Fujian Maternity and Child Health Hospital Affiliated Hospital of Fujian Medical University, China
Qiuyu Tang
Department of Pediatrics, Fujian Children’s Hospital, China
Department of Pediatrics, Fujian Maternity and Child Health Hospital Affiliated Hospital of Fujian Medical University, China
Ping Chen
Department of Medical Administration Fujian Children’s Hospital, Fuzhou Fujian, China
Department of Medical Administration Fujian Maternity and Child Health Hospital, Affiliated Hospital of Fujian Medical University, China
Chengyi Wang
Department of Pediatrics, Fujian Children’s Hospital, China
Department of Pediatrics, Fujian Maternity and Child Health Hospital Affiliated Hospital of Fujian Medical University, China
Guanghua Liu
Department of Pediatrics, Fujian Children’s Hospital, China
Department of Pediatrics, Fujian Maternity and Child Health Hospital Affiliated Hospital of Fujian Medical University, China
Language: English
Page range: 415 - 425
Accepted on: Sep 20, 2021
Published on: Apr 13, 2022
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2022 Shihao Zhuang, Qiuyu Tang, Ping Chen, Chengyi Wang, Guanghua Liu, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.